血液透析・腹膜透析の世界市場2020–2027:種類別(血液透析、腹膜透析)、透析部位別、モダリティ別、製品別

◆英語タイトル:Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Global Opportunity Analysis and Industry Forecast, 2020–2027
◆商品コード:AMR20SP035
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年7月
◆ページ数:262
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,269 ⇒換算¥689,590見積依頼/購入/質問フォーム
5 UserUSD7,050 ⇒換算¥775,500見積依頼/購入/質問フォーム
Enterprise UserUSD9,832 ⇒換算¥1,081,520見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは血液透析・腹膜透析の世界市場について詳細に調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、種類別(血液透析(HD)、腹膜透析(PD))分析、透析場所別(病院、クリニック・透析センター、在宅透析)分析、モダリティ別(従来型透析、毎日透析(日中/夜間))分析、製品別(デバイス、消耗品)分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・血液透析・腹膜透析の世界市場規模:種類別(血液透析(HD)、腹膜透析(PD))
・血液透析・腹膜透析の世界市場規模:透析場所別(病院、クリニック・透析センター、在宅透析)
・血液透析・腹膜透析の世界市場規模:モダリティ別(従来型透析、毎日透析(日中/夜間))
・血液透析・腹膜透析の世界市場規模:製品別(デバイス、消耗品)
・血液透析・腹膜透析の世界市場規模:地域別
・企業情報
【レポートの概要】

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys. The procedure is vital during the treatment of end-stage renal disease (ESRD) and chronic kidney disease (CKD). Dialysis can be performed in two ways, namely; hemodialysis and peritoneal dialysis. In hemodialysis (HD), a filter is used to remove the waste products and extra fluids from blood. The purified blood is then reintroduced into the patient’s body. On the other hand, peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen, called peritoneum and a dialysis solution to clean and purify blood and reinstate it into the patient’s body. Both hemodialysis and peritoneal dialysis work on a similar principle of purifying the blood and removing toxins from patient’s body, when kidneys are unable to function normally.

The global hemodialysis and peritoneal dialysis market was valued at $15,681.81 million in 2019, and is projected to reach $22,164.86 million by 2027, registering a CAGR of 6.0%. This market growth is attributed to surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are projected to further supplement the global hemodialysis and peritoneal dialysis market growth. Conversely, rise in complications related to dialysis treatment such as infections, hypotension, fluid overload, and access point bleeding are likely to obstruct growth of the market in the coming years.

Similarly, reimbursement policy concerns in emerging nations impedes growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach and surge in market strategies such as acquisitions, partnerships, product development, and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.

The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. By type, it is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into short-term catheter, chronic catheter, graft, and fistula. By dialysis site, the market is classified into hospitals, clinics & dialysis centers, and home dialysis. By modality, it is categorized into conventional and daily (day time, night time). By product, it is segmented into devices and consumables. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
 This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
 An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
 A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysismarket is provided.
 An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS
By Type
o Hemodialysis
 Short-term Catheter
 Chronic Catheter
 Graft
 Fistula
o Peritoneal Dialysis

By Dialysis Site
o Hospitals
o Clinics &Dialysis Centers
o Home Dialysis

By Modality
o Conventional
o Daily (Day Time, Night Time)

By Product
o Devices
o Consumables

By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 UK
 France
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Australia
 South Korea
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 South Africa
 Rest of LAMEA
KEY MARKET PLAYERS
• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• Nipro Corporation
• B Braun Melsungen Ag
• Nikkiso Co., Ltd.
• Becton, Dickinson And Company (C. R. Bard, Inc.)
• Cook Group
• Angiodynamics Inc.
• Medtronic PLC
• Asahi Kasei Corp.

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Surge in incidences of kidney diseases
3.5.1.2.Issues associated with kidney transplants
3.5.1.3.Rise in prevalence of lifestyle and chronic diseases

3.5.2.Restraints

3.5.2.1.Complications in dialysis treatment
3.5.2.2.Reimbursement policy concerns in emerging nations

3.5.3.Opportunities

3.5.3.1.Shift in preference of patients for home hemodialysis
3.5.3.2.Surge in market strategies by key players

3.6.Prevalence and Incidence of HD and PD: Important demographics
3.7.Pricing analysis
3.8.Average survival time of vascular access products
3.9.Reimbursement scenario for dialysis (per patient)
3.10.List of major morbidities associated with hemodialysis access procedures
3.11.List of major companies delivering dialysis services

CHAPTER 4:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Hemodialysis (HD)

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Short-term Catheter (Non-cuffed tunneled catheters)
4.2.5.Chronic Catheter (Cuffed tunneled catheters)
4.2.6.Graft (AVG)
4.2.7.Fistula (AVF)

4.3.Peritoneal dialysis (PD)

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country

CHAPTER 5:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals

5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.Clinics & dialysis centers

5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

5.4.Home dialysis

5.4.1.Key market trends and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country

CHAPTER 6:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY

6.1.Overview

6.1.1.Market size and forecast

6.2.Conventional dialysis

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market share analysis, by country

6.3.Daily dialysis (Day time/ Night time)

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market share analysis, by country

CHAPTER 7:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT

7.1.Overview

7.1.1.Market size and forecast

7.2.Devices

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.2.3.Market share analysis, by country

7.3.Consumables

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.3.3.Market share analysis, by country

CHAPTER 8:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.Market size and forecast, by country
8.2.3.Market size and forecast, by type
8.2.4.Market size and forecast, by dialysis site
8.2.5.Market size and forecast, by modality
8.2.6.Market size and forecast, by product
8.2.7.U.S.

8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by dialysis site
8.2.7.3.Market size and forecast, by modality
8.2.7.4.Market size and forecast, by product

8.2.8.Canada

8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by dialysis site
8.2.8.3.Market size and forecast, by modality
8.2.8.4.Market size and forecast, by product

8.2.9.Mexico

8.2.9.1.Market size and forecast, by type
8.2.9.2.Market size and forecast, by dialysis site
8.2.9.3.Market size and forecast, by modality
8.2.9.4.Market size and forecast, by product

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Market size and forecast, by country
8.3.3.Market size and forecast, by type
8.3.4.Market size and forecast, by dialysis site
8.3.5.Market size and forecast, by modality
8.3.6.Market size and forecast, by product
8.3.7.UK

8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by dialysis site
8.3.7.3.Market size and forecast, by modality
8.3.7.4.Market size and forecast, by product

8.3.8.France

8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by dialysis site
8.3.8.3.Market size and forecast, by modality
8.3.8.4.Market size and forecast, by product

8.3.9.Spain

8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by dialysis site
8.3.9.3.Market size and forecast, by modality
8.3.9.4.Market size and forecast, by product

8.3.10.Italy

8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by dialysis site
8.3.10.3.Market size and forecast, by modality
8.3.10.4.Market size and forecast, by product

8.3.11.Germany

8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by dialysis site
8.3.11.3.Market size and forecast, by modality
8.3.11.4.Market size and forecast, by product

8.3.12.Rest of Europe

8.3.12.1.Market size and forecast, by type
8.3.12.2.Market size and forecast, by dialysis site
8.3.12.3.Market size and forecast, by modality
8.3.12.4.Market size and forecast, by product

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Market size and forecast, by country
8.4.3.Market size and forecast, by type
8.4.4.Market size and forecast, by dialysis site
8.4.5.Market size and forecast, by modality
8.4.6.Market size and forecast, by product
8.4.7.Japan

8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by dialysis site
8.4.7.3.Market size and forecast, by modality
8.4.7.4.Market size and forecast, by product

8.4.8.China

8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by dialysis site
8.4.8.3.Market size and forecast, by modality
8.4.8.4.Market size and forecast, by product

8.4.9.Australia

8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by dialysis site
8.4.9.3.Market size and forecast, by modality
8.4.9.4.Market size and forecast, by product

8.4.10.India

8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by dialysis site
8.4.10.3.Market size and forecast, by modality
8.4.10.4.Market size and forecast, by product

8.4.11.South Korea

8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by dialysis site
8.4.11.3.Market size and forecast, by modality
8.4.11.4.Market size and forecast, by product

8.4.12.Rest of Asia-Pacific

8.4.12.1.Market size and forecast, by type
8.4.12.2.Market size and forecast, by dialysis site
8.4.12.3.Market size and forecast, by modality
8.4.12.4.Market size and forecast, by product

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.Market size and forecast, by country
8.5.3.Market size and forecast, by type
8.5.4.Market size and forecast, by dialysis site
8.5.5.Market size and forecast, by modality
8.5.6.Market size and forecast, by product
8.5.7.Brazil

8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by dialysis site
8.5.7.3.Market size and forecast, by modality
8.5.7.4.Market size and forecast, by product

8.5.8.Saudi Arabia

8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by dialysis site
8.5.8.3.Market size and forecast, by modality
8.5.8.4.Market size and forecast, by product

8.5.9.South Africa

8.5.9.1.Market size and forecast, by type
8.5.9.2.Market size and forecast, by dialysis site
8.5.9.3.Market size and forecast, by modality
8.5.9.4.Market size and forecast, by product

8.5.10.Rest of LAMEA

8.5.10.1.Market size and forecast, by type
8.5.10.2.Market size and forecast, by dialysis site
8.5.10.3.Market size and forecast, by modality
8.5.10.4.Market size and forecast, by product

CHAPTER 9:COMPANY PROFILES

9.1.FRESENIUS SE AND CO. KGAA

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.ASAHI KASEI CORPORATION

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance

9.3.B. BRAUN MELSUNGEN AG

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments

9.4.BAXTER INTERNATIONAL INC.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments

9.6.COOK GROUP

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio

9.7.ANGIODYNAMICS INC.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance

9.8.MEDTRONIC PLC.

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.NIKKISO CO. LTD.

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance

9.10.NIPRO CORPORATION

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance

LIST OF TABLES

TABLE 01.SIDE EFFECTS OF DIALYSIS
TABLE 02.PREVALENCE AND INCIDENCE OF HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENT (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 03.PRICING ANALYSIS BY ACCESS TYPE: AVERAGE PRICING RANGE (USD)
TABLE 04.AVERAGE SURVIVAL TIME OF VASCULAR ACCESS PRODUCTS
TABLE 05.ACCESS FISTULA AND GRAFTS
TABLE 06.ACCESS CATHETERS
TABLE 07.LIST OF MAJOR COMPANIES DELIVERING DIALYSIS SERVICES
TABLE 08.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 09.GLOBAL HEMODIALYSIS PATIENTS, BY ACCESS TYPE (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 10.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GLOBAL HEMODIALYSIS PATIENTS WITH SHORT TERM CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 12.GLOBAL HEMODIALYSIS PATIENTS WITH CHRONIC CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 13.GLOBAL HEMODIALYSIS PATIENTS WITH GRAFT ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 14.GLOBAL HEMODIALYSIS FISTULA MARKET, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 15.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 16.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 17.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 20.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 21.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 22.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 23.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 24.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 25.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY REGION, 2019–2027 ($MILLION)
TABLE 26.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 30.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 31.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 32.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 33.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 34.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 35.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 36.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 37.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 38.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 39.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 40.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 42.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 43.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 44.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 45.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 46.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 47.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 48.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 49.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 50.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 51.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 52.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 53.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 54.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 55.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 56.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 57.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 58.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 59.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 60.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 61.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 62.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 63.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 64.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 65.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 66.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 67.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 68.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 69.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 70.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 71.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 72.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 73.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 74.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 75.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 76.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 77.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 78.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 79.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 80.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 81.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 82.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 83.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 84.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 85.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 86.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 87.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 88.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 89.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 90.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 91.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 92.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 93.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 94.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 95.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 96.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 97.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 98.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 99.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 100.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 101.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 102.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 103.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 104.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 105.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 106.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 107.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 108.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 109.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 110.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 111.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 112.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 113.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 114.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 115.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 116.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 117.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 118.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 119.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 120.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 121.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 122.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 123.FRESENIUS: COMPANY SNAPSHOT
TABLE 124.FRESENIUS: OPERATING SEGMENTS
TABLE 125.FRESENIUS: PRODUCT PORTFOLIO
TABLE 126.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.ASAHI KASEI: COMPANY SNAPSHOT
TABLE 128.ASAHI KASEI: OPERATING SEGMENTS
TABLE 129.ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 130.B. BRAUN: COMPANY SNAPSHOT
TABLE 131.B. BRAUN: OPERATING SEGMENTS
TABLE 132.B. BRAUN: PRODUCT PORTFOLIO
TABLE 133.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134.BAXTER: COMPANY SNAPSHOT
TABLE 135.BAXTER: OPERATING SEGMENTS
TABLE 136.BAXTER: PRODUCT PORTFOLIO
TABLE 137.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138.BD: COMPANY SNAPSHOT
TABLE 139.BD: OPERATING SEGMENTS
TABLE 140.BD: PRODUCT PORTFOLIO
TABLE 141.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 142.COOK: COMPANY SNAPSHOT
TABLE 143.COOK: OPERATING SEGMENTS
TABLE 144.COOK: PRODUCT PORTFOLIO
TABLE 145.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 146.ANGIODYNAMICS: PRODUCT SEGMENTS
TABLE 147.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 148.MEDTRONIC: COMPANY SNAPSHOT
TABLE 149.MEDTRONIC: OPERATING SEGMENTS
TABLE 150.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 151.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 152.NIKKISO: COMPANY SNAPSHOT
TABLE 153.NIKKISO: OPERATING SEGMENTS
TABLE 154.NIKKISO: PRODUCT PORTFOLIO
TABLE 155.NIPRO: COMPANY SNAPSHOT
TABLE 156.NIPRO: OPERATING SEGMENTS
TABLE 157.NIPRO: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.SEGMENTATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 02.TOP INVESTMENT POCKETS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016–2019*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016–2019* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016–2019*
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.RESTRAINTS AND DRIVERS: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 13.PROJECTED PREVALENCE OF CKD IN 2020 AND 2030 IN ADULTS AGED 30 YEARS OR OLDER (U.S.)
FIGURE 14.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
FIGURE 15.DIALYSIS REIMBURSEMENT SCENARIO AROUND THE WORLD
FIGURE 16.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 25.GLOBAL PREVALENCE OF DIALYSIS, RATE PER MILLION POPULATION (PMP), AGE ≥ 18 YEARS
FIGURE 26.TRENDS IN ANNUAL NUMBER OF ESRD INCIDENT CASES AND STANDARD INCIDENCES RATES PER MILLION EACH YEAR, U.S.
FIGURE 27.FRESENIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 29.FRESENIUS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 30.ASAHI KASEI: NET SALES, 2017–2019 ($MILLION)
FIGURE 31.ASAHI KASEI: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 32.ASAHI KASEI: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 33.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.BAXTER: NET SALES, 2017–2019 ($MILLION)
FIGURE 37.BAXTER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 38.BAXTER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 39.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 41.BD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 42.ANGIODYNAMICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 44.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.NIKKISO: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.NIKKISO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.NIKKISO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.NIPRO: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.NIPRO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.NIPRO: REVENUE SHARE, BY REGION, 2019 (%)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血液透析・腹膜透析の世界市場2020–2027:種類別(血液透析、腹膜透析)、透析部位別、モダリティ別、製品別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆